NO20032143L - Fremgangsmate for produksjon i stor skala av rekombinant DNA-avledede TPA- eller K2S-molekyler - Google Patents

Fremgangsmate for produksjon i stor skala av rekombinant DNA-avledede TPA- eller K2S-molekyler

Info

Publication number
NO20032143L
NO20032143L NO20032143A NO20032143A NO20032143L NO 20032143 L NO20032143 L NO 20032143L NO 20032143 A NO20032143 A NO 20032143A NO 20032143 A NO20032143 A NO 20032143A NO 20032143 L NO20032143 L NO 20032143L
Authority
NO
Norway
Prior art keywords
molecules
production process
recombinant dna
large scale
scale production
Prior art date
Application number
NO20032143A
Other languages
English (en)
Other versions
NO20032143D0 (no
Inventor
Rolf-Guenter Werner
Friedrich Goetz
Chatchei Tayapiwatana
Jiradej Manosroi
Aranya Manosroi
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO20032143D0 publication Critical patent/NO20032143D0/no
Publication of NO20032143L publication Critical patent/NO20032143L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
NO20032143A 2000-11-14 2003-05-13 Fremgangsmate for produksjon i stor skala av rekombinant DNA-avledede TPA- eller K2S-molekyler NO20032143L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0027779.8A GB0027779D0 (en) 2000-11-14 2000-11-14 Methods for large scale production of recombinant dna-derived tpa or k2s molecules
PCT/EP2001/012857 WO2002040650A2 (en) 2000-11-14 2001-11-07 Methods for large scale production of recombinant dna-derived tpa or k2s molecules

Publications (2)

Publication Number Publication Date
NO20032143D0 NO20032143D0 (no) 2003-05-13
NO20032143L true NO20032143L (no) 2003-07-07

Family

ID=9903153

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032143A NO20032143L (no) 2000-11-14 2003-05-13 Fremgangsmate for produksjon i stor skala av rekombinant DNA-avledede TPA- eller K2S-molekyler

Country Status (31)

Country Link
EP (1) EP1407030B1 (no)
JP (1) JP2004520018A (no)
KR (1) KR100856346B1 (no)
CN (1) CN100567495C (no)
AR (1) AR031334A1 (no)
AT (1) ATE504652T1 (no)
AU (2) AU2181502A (no)
BG (1) BG66121B1 (no)
BR (1) BR0115344A (no)
CA (1) CA2428642C (no)
CZ (1) CZ20031657A3 (no)
DE (1) DE60144395D1 (no)
EA (1) EA005163B1 (no)
EC (1) ECSP034573A (no)
EE (1) EE200300232A (no)
GB (1) GB0027779D0 (no)
HR (1) HRP20030377A2 (no)
HU (1) HUP0301619A3 (no)
IL (2) IL155568A0 (no)
MX (1) MXPA03004161A (no)
MY (1) MY129838A (no)
NO (1) NO20032143L (no)
NZ (1) NZ526280A (no)
PL (1) PL206783B1 (no)
SK (1) SK5792003A3 (no)
TW (1) TWI292782B (no)
UA (1) UA75102C2 (no)
UY (1) UY27020A1 (no)
WO (1) WO2002040650A2 (no)
YU (1) YU36103A (no)
ZA (1) ZA200303547B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6955910B2 (en) 2000-11-14 2005-10-18 Boehringer Ingelheim International Gmbh Method for large scale production of recombinant DNA-derived TPA or K2S molecules
US7087412B2 (en) 2000-11-14 2006-08-08 Boehringer Ingelheim International Gmbh Methods for large scale protein production in prokaryotes
IL190184A0 (en) * 2008-03-16 2009-02-11 Hadasit Med Res Service tPA MUTANT IN THE TREATMENT OF ACUTE BRAIN INJURY AND NEURODEGENERATIVE DISORDERS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87276A (en) * 1987-08-03 1995-07-31 Fujisawa Pharmaceutical Co Analog of tissue plasminogen activator comprising only the kringle 2 and protease domain dna encoding the same processes for the preparation thereof and pharmaceutical compositions containing the same
AU2660397A (en) * 1996-04-05 1997-10-29 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells
US20020061576A1 (en) * 1997-05-28 2002-05-23 Paul A. Moore Tissue plasminogen activator-like protease
US6083715A (en) * 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
EP1048732A1 (de) * 1999-04-26 2000-11-02 F. Hoffmann-La Roche Ag Verfahren zur Herstellung von natürlich gefalteten und sekretierten Proteinen
EP1077263A1 (de) * 1999-07-29 2001-02-21 F.Hoffmann-La Roche Ag Verfahren zur Herstellung von natürlich gefalteten und sekretierten Proteinen durch Co-Sekretion von Chaperonen
GB0027782D0 (en) * 2000-11-14 2000-12-27 Boehringer Ingelheim Int Methods fro large scale protein productio in prokaryotes

Also Published As

Publication number Publication date
CA2428642C (en) 2010-03-30
PL206783B1 (pl) 2010-09-30
JP2004520018A (ja) 2004-07-08
BR0115344A (pt) 2003-08-26
HK1070097A1 (zh) 2005-06-10
HRP20030377A2 (en) 2005-04-30
BG66121B1 (bg) 2011-05-31
WO2002040650A2 (en) 2002-05-23
YU36103A (sh) 2006-05-25
SK5792003A3 (en) 2004-01-08
ECSP034573A (es) 2003-05-26
WO2002040650A3 (en) 2003-12-31
HUP0301619A3 (en) 2006-11-28
TWI292782B (en) 2008-01-21
ZA200303547B (en) 2004-05-10
IL155568A (en) 2010-02-17
ATE504652T1 (de) 2011-04-15
CN1541271A (zh) 2004-10-27
NO20032143D0 (no) 2003-05-13
DE60144395D1 (de) 2011-05-19
PL361881A1 (en) 2004-10-04
NZ526280A (en) 2006-02-24
KR100856346B1 (ko) 2008-09-04
EE200300232A (et) 2003-10-15
AR031334A1 (es) 2003-09-17
CA2428642A1 (en) 2002-05-23
UY27020A1 (es) 2002-07-31
EA200300502A1 (ru) 2003-12-25
MY129838A (en) 2007-05-31
AU2181502A (en) 2002-05-27
AU2002221815B2 (en) 2007-08-23
EP1407030B1 (en) 2011-04-06
BG107780A (bg) 2004-02-27
EP1407030A2 (en) 2004-04-14
KR20030059252A (ko) 2003-07-07
EA005163B1 (ru) 2004-12-30
CZ20031657A3 (cs) 2003-10-15
GB0027779D0 (en) 2000-12-27
MXPA03004161A (es) 2004-04-20
HUP0301619A2 (hu) 2003-09-29
CN100567495C (zh) 2009-12-09
IL155568A0 (en) 2003-11-23
UA75102C2 (en) 2006-03-15

Similar Documents

Publication Publication Date Title
DE60139122D1 (de) Verfahren zur produktion von natürlichen medizin präparaten
NO20024319L (no) Fremgangsmåte og anordning for syretilsetning av hydrokarbonkilder
NO20024005L (no) Pteridinforbindelser for behandling av psoriasis
NO20042159L (no) Cellokulturprosess
NO961812D0 (no) Humanproteaseinhibitorer av Kunitz-type
NO20005614D0 (no) Nukleinsyremolekyler som koder for enzymer avledet fra hvete og som er involvert i syntese av stivelse
DK1341414T3 (da) Marint actinomycet-taxon til opdagelse af medikamenter og fermenteringsprodukter
NO20032822L (no) Fremgangsmate for konsentrering av brukt syre
DE69822473D1 (de) Lipid-polyamid-konjugate und zusammensetzungen zur verabreichung von nucleinsäuremolekülen
DE602004029609D1 (de) Navigationssystem und Computerprogrammprodukt
NO20024926D0 (no) Materialer og fremgangsmåter for den biologiske produksjon av svovelsyre
DE69637579D1 (de) Methode zur Amplifizierung von Nukleinsäure und entsprechende Regenzien dafür
DE50114998D1 (de) Verfahren zur herstellung von monolithischen chromatographiesäulen
DE50101924D1 (de) Multiplex-sequenzierungsverfahren
NO20020499L (no) Fremgangsmåte og system for drift og forbedring av produksjonen i brönner
NO20030772D0 (no) Fremgangsmåte til fremstilling av vannfritt azitromycin
ID27270A (id) Aparatus pemroses informasi program siaran
DE50103793D1 (de) Silicatein-vermittelte synthese von amorphen silikaten und siloxanen und ihre verwendung
FI970832A0 (fi) Biologisen materiaalin, kuten nukleiinihapon, erottamiseen käytettävä laite
NO20022282L (no) Fremgangsmåte for fremstilling av biopolymerer av nitrogenfattig avlöpsvann
DK1082423T3 (da) Cyclin E2-gener og -proteiner
FI20010272A0 (fi) Parannettu menetelmä erittyvien proteiinien tuottamiseksi sienissä
NO20031413D0 (no) Ny fremgangsmåte for fremstilling av oksabispidiner
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
TR200402030T4 (tr) İkame edilen I-aminobutan-3-ol-türevleri

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application